European SARS-CoV-2 and influenza virus Bioinformatics External Quality Assessment (ESIB-EQA), 2025
SARS-CoV-2 and influenza viruses are significant public health threats with varying impacts on global health. SARSCoV- 2, the virus behind the COVID-19 pandemic, exhibits high transmissibility where variants such as Beta, Delta, and Omicron emerged and caused epidemiological waves. Seasonal influenza continues to cause significant illness and death worldwide, emphasising the importance of ongoing research and surveillance to improve prevention and control. Both SARS-CoV-2 and influenza challenge public health efforts due to their continuous evolution, necessitating ongoing surveillance, vaccine development, and strategic response measures.
Executive summary
Surveillance and Laboratory Networks
Surveillance for SARS-CoV-2 and influenza involves data collection, analysis, and interpretation to guide public health actions. The European Centre for Disease Prevention and Control (ECDC) sets surveillance objectives including monitoring epidemiological, clinical and virological changes and characteristics as well as assessing burden of disease and interventions. External Quality Assessment (EQA) programs support these objectives by ensuring laboratory accuracy and reliability.
ECDC coordinates the laboratory networks of the European Respiratory Viruses Network (ERVI-Net) which covers virological surveillance, laboratory capacity, and data sharing across Europe. These networks play a pivotal role in case detection, confirmation, and characterisation, contributing to effective public health responses.
Bioinformatics EQA
The ESIB-EQA assesses the capability of laboratories in public health bioinformatics for SARS-CoV-2 and influenza virus. It aims to provide troubleshooting advice and improve quality through training activities. This third iteration, conducted in 2025, focused on consensus sequence generation and quality control for both viruses, revealing several areas for improvement in laboratory practices.
European SARS-CoV-2 and influenza virus Bioinformatics External Quality Assessment (ESIB-EQA), 2025
English (3.41 MB - PDF)